Literature DB >> 33476327

SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.

Michihito Sasaki1, Kentaro Uemura1,2,3, Akihiko Sato1,2, Shinsuke Toba1,2, Takao Sanaki1,2, Katsumi Maenaka3,4, William W Hall5,6,7, Yasuko Orba1,5, Hirofumi Sawa1,5,7.   

Abstract

The spike (S) protein of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) binds to a host cell receptor which facilitates viral entry. A polybasic motif detected at the cleavage site of the S protein has been shown to broaden the cell tropism and transmissibility of the virus. Here we examine the properties of SARS-CoV-2 variants with mutations at the S protein cleavage site that undergo inefficient proteolytic cleavage. Virus variants with S gene mutations generated smaller plaques and exhibited a more limited range of cell tropism compared to the wild-type strain. These alterations were shown to result from their inability to utilize the entry pathway involving direct fusion mediated by the host type II transmembrane serine protease, TMPRSS2. Notably, viruses with S gene mutations emerged rapidly and became the dominant SARS-CoV-2 variants in TMPRSS2-deficient cells including Vero cells. Our study demonstrated that the S protein polybasic cleavage motif is a critical factor underlying SARS-CoV-2 entry and cell tropism. As such, researchers should be alert to the possibility of de novo S gene mutations emerging in tissue-culture propagated virus strains.

Entities:  

Year:  2021        PMID: 33476327     DOI: 10.1371/journal.ppat.1009233

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  57 in total

1.  The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.

Authors:  Thomas P Peacock; Daniel H Goldhill; Jie Zhou; Laury Baillon; Rebecca Frise; Olivia C Swann; Ruthiran Kugathasan; Rebecca Penn; Jonathan C Brown; Raul Y Sanchez-David; Luca Braga; Maia Kavanagh Williamson; Jack A Hassard; Ecco Staller; Brian Hanley; Michael Osborn; Mauro Giacca; Andrew D Davidson; David A Matthews; Wendy S Barclay
Journal:  Nat Microbiol       Date:  2021-04-27       Impact factor: 17.745

2.  A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses.

Authors:  Alberto A Amarilla; Julian D J Sng; Rhys Parry; Joshua M Deerain; James R Potter; Yin Xiang Setoh; Daniel J Rawle; Thuy T Le; Naphak Modhiran; Xiaohui Wang; Nias Y G Peng; Francisco J Torres; Alyssa Pyke; Jessica J Harrison; Morgan E Freney; Benjamin Liang; Christopher L D McMillan; Stacey T M Cheung; Darwin J Da Costa Guevara; Joshua M Hardy; Mark Bettington; David A Muller; Fasséli Coulibaly; Frederick Moore; Roy A Hall; Paul R Young; Jason M Mackenzie; Jody Hobson-Peters; Andreas Suhrbier; Daniel Watterson; Alexander A Khromykh
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 14.919

3.  The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.

Authors:  Wei Zou; Min Xiong; Siyuan Hao; Elizabeth Yan Zhang; Nathalie Baumlin; Michael D Kim; Matthias Salathe; Ziying Yan; Jianming Qiu
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

4.  Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union.

Authors:  Suzy Huijghebaert; Guido Vanham; Myriam Van Winckel; Karel Allegaert
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

5.  The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.

Authors:  Helena Winstone; Maria Jose Lista; Alisha C Reid; Clement Bouton; Suzanne Pickering; Rui Pedro Galao; Claire Kerridge; Katie J Doores; Chad M Swanson; Stuart J D Neil
Journal:  J Virol       Date:  2021-04-12       Impact factor: 5.103

6.  Proinflammatory responses in SARS-CoV-2 infected and soluble spike glycoprotein S1 subunit activated human macrophages.

Authors:  Kim Chiok; Kevin Hutchison; Lindsay Grace Miller; Santanu Bose; Tanya A Miura
Journal:  bioRxiv       Date:  2021-06-15

Review 7.  Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options.

Authors:  Gashaw Dessie; Tabarak Malik
Journal:  Infect Drug Resist       Date:  2021-05-24       Impact factor: 4.003

Review 8.  SARS-CoV-2 one year on: evidence for ongoing viral adaptation.

Authors:  Thomas P Peacock; Rebekah Penrice-Randal; Julian A Hiscox; Wendy S Barclay
Journal:  J Gen Virol       Date:  2021-04       Impact factor: 3.891

9.  A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic.

Authors:  Andreas C Chrysostomou; Bram Vrancken; George Koumbaris; George Themistokleous; Antonia Aristokleous; Christina Masia; Christina Eleftheriou; Costakis Iοannou; Dora C Stylianou; Marios Ioannides; Panagiotis Petrou; Vasilis Georgiou; Amalia Hatziyianni; Philippe Lemey; Anne-Mieke Vandamme; Philippos P Patsalis; Leondios G Kostrikis
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

10.  Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.

Authors:  Abdou Nagy; Shereen Basiouni; Rokshana Parvin; Hafez M Hafez; Awad A Shehata
Journal:  Arch Virol       Date:  2021-07-13       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.